Your browser doesn't support javascript.
loading
Surgical management and outcomes of spinal metastasis of malignant adrenal tumor: A retrospective study of six cases and literature review.
Ni, Xiangzhi; Wang, Jing; Cao, Jiashi; Zhang, Kun; Hou, Shuming; Huang, Xing; Song, Yuanjin; Gao, Xin; Xiao, Jianru; Liu, Tielong.
Afiliação
  • Ni X; Department of Orthopaedic Oncology, Changzheng Hospital of the Navy Medical University, Shanghai, China.
  • Wang J; Department of Orthopaedic Oncology, Changzheng Hospital of the Navy Medical University, Shanghai, China.
  • Cao J; Department of Orthopedics, No. 455 Hospital of Chinese People's Liberation Army, The Navy Medical University, Shanghai, China.
  • Zhang K; Department of Orthopaedic Oncology, Changzheng Hospital of the Navy Medical University, Shanghai, China.
  • Hou S; Department of Orthopaedic Oncology, Changzheng Hospital of the Navy Medical University, Shanghai, China.
  • Huang X; Department of Orthopaedic Oncology, Changzheng Hospital of the Navy Medical University, Shanghai, China.
  • Song Y; Department of Orthopaedics, The 80th Group Army Hospital, Weifang, Shandong, China.
  • Gao X; Department of Orthopaedic Oncology, Changzheng Hospital of the Navy Medical University, Shanghai, China.
  • Xiao J; Department of Orthopaedic Oncology, Changzheng Hospital of the Navy Medical University, Shanghai, China.
  • Liu T; Department of Orthopaedic Oncology, Changzheng Hospital of the Navy Medical University, Shanghai, China.
Front Oncol ; 13: 1110045, 2023.
Article em En | MEDLINE | ID: mdl-36776311
ABSTRACT

Purpose:

Spinal metastasis of malignant adrenal tumor (SMMAT) is an extremely rare and poorly understood malignant tumor originating from the adrenal gland. The objective of this study is to elucidate the clinical characteristics and discuss surgical management and outcomes of SMMAT.

Methods:

Included in this study were six SMMAT patients who received surgical treatment in our center between February 2013 and May 2022. Their clinical data and outcomes were retrospectively analyzed to gain a better understanding of SMMAT. In addition, ten cases from the literature focusing on SMMAT were also reviewed.

Results:

Surgery was performed successfully, and the associated symptoms were relieved significantly in all patients postoperatively. The mean follow-up duration was 26.2 (range 3-55) months. Two patients died of tumor recurrence 12 and 48 months after operation respectively. The other four patients were alive at the last follow-up.

Conclusions:

The prognosis of SMMAT is usually poor. Preoperative embolization and early surgical radical resection can offer satisfactory clinical outcomes. The patient's health status, preoperative neurological function, tumor location and the resection mode are potential prognostic factors of SMMAT.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
...